The 1 analysts offering 12-month price forecasts for Lumos Pharma Inc have a median target of 36.00, with a high estimate of 36.00 and a low estimate of 36.00. The median estimate represents a +304.27% increase from the last price of 8.90.
The current consensus among 1 polled investment analysts is to Hold stock in Lumos Pharma Inc. This rating has held steady since June, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share --
Reporting Date TBD
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.